To examine if Sox3 has a similar regulatory capacity in glioma cells as in NSCs, we transfected primary cultures derived from human grade IV gliomas with vectors expressing either full-length Sox3, a dominant negative version of Sox3 (Sox3EnR-Myc) [9] or enhanced GFP (EGFP). The gene discussed is SOX3; the disease is glioma.